NavaDerm Partners adds Dan Wechsler as Executive Chairman
Dan is a highly experienced practice management leader and senior pharmaceutical executive. Previously, Dan served as President and CEO of Smile Brands, a privately held dental service organization with 4,500 employees (including 700 general and specialty dentists) and more than 360 offices. Prior to Smile Brands, Dan served as EVP and Global President of Pharmaceuticals at Bausch + Lomb. Dan was previously an executive at Merck & Co., Schering-Plough, Pfizer Inc., Melinta Therapeutics, and
DanĀ stated, "I am excited to joinĀ NavaDermĀ and help support
Dr. John Murphy,Ā NavaDerm CEO and Board Director,Ā addedĀ "We are thrilled to have Dan join NavaDerm. Ā Dan is a seasoned practice management and pharma executive and we are fortunate to have someone of his caliber join our team. We are building a best-in-class corporate organization to support our outstanding dermatologists and Dan's experience in scaling organizations will be invaluable as we continue to execute on our plan. We are focused on accelerating growth while maintaining our core mission - partnering with terrific dermatologists and their dedicated staffs and support them in providing exceptional patient care."Ā
AboutĀ NavaDerm
NavaDermĀ Partners, headquartered in
AboutĀ BelHealthĀ Investment PartnersĀ
BelHealthĀ Investment Partners, based in
For further information, please visit:
NavaDerm: www.navaderm.com
View original content:http://www.prnewswire.com/news-releases/navaderm-partners-adds-dan-wechsler-as-executive-chairman-300967466.html
SOURCE
How To Select A Safer And Cheaper To Insure Car – New Guide
Outlook on Canada’s Dental Devices Market – Growth, Trends & Forecasts, 2019-2024 – ResearchAndMarkets.com
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News